Background
==========

The implementation of informative BRCA1 testing programs is aided by acquisition of population-specific genetic data. From this it emerges that a number of mutations have been found repeatedly, and specific mutations are common in defined populations. This can be referred to a founder effect that in human genetics refers to the presence of genetic disorders that are either endemic to an isolated population or are very rare elsewhere. In a previous population-based study we described the first example of a founder BRCA1 mutation in Italy, with a strong recurrence of the 5083del19 in high-risk patients all of Calabrian origin selected for family history of the disease \[[@B1]\]. The same mutation accounts in Canada for a significant percentage of women of Italian ancestry with breast--ovarian cancer \[[@B2]\].

The aim of this study was to investigate the extent to which the 5083del19 mutation contributed to breast--ovarian cancer incidence in Calabria, and to perform some genotype--phenotype correlations.

Methods
=======

We tested 70 paraffin-embedded tissue specimens from a consecutive series of breast or ovarian cancer cases. It is estimated that our tissue archive collects more than 90% of incident cancers in the Catanzaro area. Archival tissue samples were genotyped only for the 5083del19 founder mutation. Immunohistochemical staining of several markers (i.e. ER, PR, Ki67, p53, HER2, CK5/6) as well as some pathological features (i.e. histology, grade) were evaluated.

Results
=======

Seven out of the 70 samples screened for this BRCA mutation had mutations. Haplotype analysis revealed a common ancestor. All cases aged in premenopausal years. The phenotype of the 5083del19 BRCA1-associated breast tumours appears characterized by a lack of expression of hormone receptors and is generally associated with high proliferation markers and poorly differentiated aspects. All cases were ductal invasive carcinomas and showed a \'basal-like\' portrait according to expression profiling studies \[[@B3]\]. The median age at diagnosis of the ovarian cancer carriers was 49 years and the histological type was serous adenocarcinoma.

Conclusion
==========

A predominant BRCA1 gene founder mutation associated with a high risk of early onset breast cancer and ovarian cancer and unfavourable immunophenotype features has been identified and found to occur in a restricted geographical area, thereby allowing timely and cost-effective mutation screening using blood samples or archival histological material.
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